Alpha-1-antitrypsin phenotype c detection and treatment of inflammation and inflammatory conditions associated with said phenotype
OwnerKevin F. LAWinventor
Life of this patent
Estimating the term…
Abstract
A method of treating a patient infected with SARS-COV-2 virus includes phenotyping a sample obtained from the patient; and administering alpha-1-antitrypsin to the patient only if an alpha-1-antitrypsin C phenotype is detected in the sample. A kit configured to detect a SARS-COV-2 infection and an alpha-1-antitrypsin C phenotype includes a first sample collection container for holding a sample to be tested for a SARS-COV-2 infection; and a second sample collection container for holding a sample to be tested for alpha-1-antitrypsin phenotype C.
Claims15
A method of treating a patient infected with SARS-COV-2 virus, said method comprising:
- phenotyping a sample obtained from the patient;
- and
- administering alpha-1-antitrypsin to the patient only if an alpha-1-antitrypsin C phenotype is detected in the sample,
- wherein the alpha-1-antitrypsin is effective to treat the patient infected with the SARS-CoV-2 virus.
A kit configured to detect a SARS-COV-2 infection and an alpha-1-antitrypsin C phenotype, said kit comprising:
- a first sample collection container for holding a sample to be tested for a SARS-COV-2 infection;
- and
- a second sample collection container for holding a sample to be tested for alpha-1-antitrypsin phenotype C.
Dependencies are inferred from the claim text.